Literature DB >> 11716176

Lung dendritic cells and host immunity to infection.

B N Lambrecht1, J B Prins, H C Hoogsteden.   

Abstract

The lung is a portal of entry for numerous microbial pathogens, against which evolution has created an adequate innate and adaptive immune response. Dendritic cells (DCs) are central to the integration of innate and specific immunity. These cells are located within the epithelium and interstitium of the lung where they are influenced by the innate immune system. Upon recognition and internalization of microbial antigens, DCs migrate to the draining lymph nodes of the lung to initiate the specific cellular and humoral immune response. By their capacity to integrate stimuli derived from the pathogen, the host and the environment, they are specialized to induce a protective immune response while at the same time avoiding damage to the host. It is becoming increasingly clear that dendritic cells are involved in the induction of immunity to viruses, bacteria, mycobacteria and fungi. Some pathogens subvert the function of dendritic cells to escape immune recognition. Not surprisingly, if dendritic cell function fails, the consequence for the host is immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716176

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  35 in total

Review 1.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 2.  Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Authors:  Stephen C Juvet; David Hwang; Gregory P Downey
Journal:  Can Respir J       Date:  2010 May-Jun       Impact factor: 2.409

3.  Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.

Authors:  Pavan Muttil; Brian Pulliam; Lucila Garcia-Contreras; John Kevin Fallon; Chenchen Wang; Anthony James Hickey; David A Edwards
Journal:  AAPS J       Date:  2010-09-28       Impact factor: 4.009

Review 4.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

5.  In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis.

Authors:  Alexander Pedroza-González; Gina S García-Romo; Diana Aguilar-León; Juana Calderon-Amador; Raquel Hurtado-Ortiz; Hector Orozco-Estevez; Bart N Lambrecht; Iris Estrada-García; Rogelio Hernández-Pando; Leopoldo Flores-Romo
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

6.  Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection.

Authors:  Taeg S Kim; Matthew M Hufford; Jie Sun; Yang-Xin Fu; Thomas J Braciale
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

7.  Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.

Authors:  John J Osterholzer; Gwo-Hsiao Chen; Michal A Olszewski; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 8.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

9.  Differential response of respiratory dendritic cell subsets to influenza virus infection.

Authors:  Xueli Hao; Taeg S Kim; Thomas J Braciale
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Role of NK cells in host defense against pulmonary type A Francisella tularensis infection.

Authors:  Deanna M Schmitt; Dawn M O'Dee; Matthew J Brown; Joseph Horzempa; Brian C Russo; Penelope A Morel; Gerard J Nau
Journal:  Microbes Infect       Date:  2012-12-01       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.